Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Elf3 encodes a novel 200-kD β-spectrin: role in liver development

Abstract

β-spectrins are crucial for the maintenance of cell shape, the establishment of cell polarity, and the formation of distinct membrane domains. Our strategy for identifying genes important for hepatocyte polarity has been to utilize subtractive hybridization of early embryonic mouse cDNA liver libraries. As a result, we have cloned three isoforms of a novel β-spectrin elf (embryonic liver β-fodrin), and here we report the analysis of elf3, the longest isoform (8172 nt). ELF3 comprises 2154 residues with an overall similarity of 89.0% and 95.3% to mouse β-spectrin (βSpIIΣS1) at the nucleotide and amino acid level, respectively. ELF3 is characterized by an actin- binding domain, a long repeat domain, and a short regulatory domain remarkable for the absence of a PH domain. Linkage analysis reveals that elf3 maps to mouse chromosome 11 between D11Bir6 and D11Xrf477, a different chromosomal locus from that of the other four spectrin genes. Northern blot analysis utilizing an elf3 3′-UTR probe demonstrates an abundant 9.0-kb transcript in brain, liver, and heart tissues. Western blot with a polyclonal antibody against ELF identifies a 200 kD protein in mouse liver, brain, kidney, and heart tissues. Immunohistochemical studies demonstrate ELF labeling of the basolateral or sinusoidal membranes surface as well as a granular cytoplasmic pattern in hepatocytes. Antisense studies utilizing cultured liver explants show a vital role of elf3 in hepatocyte differentiation and intrahepatic bile duct formation. The differential expression, tissue localization, and functional studies demonstrate the importance of elf3 in modulating interactions between various components of the cytoskeleton proteins controlling liver and bile duct development.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

References

  • Altschul SF and Gish W. . 1996 Methods Enzymol. 266: 460–480.

  • Beck KA and Nelson WJ. . 1996 Am. J. Physiol. 270: C1263–1270.

  • Bennett V, Davis J and Fowler WE. . 1982 Nature 299: 126–131.

  • Bennett V and Gilligan DM. . 1993 Annu. Rev. Cell Biol. 9: 27–66.

  • Blakeslee D. . 1977 J. Immunol. Methods 17: 361–364.

  • Bouwens L, De Bleser P, Vanderkerken K, Geerts B and Wisse E. . 1992 Enzyme 46: 155–168.

  • Cai T, Yu P, Monga SPS, Mishra B and Mishra L. . 1998 Biochim. Biophys. ACTA 1390: In press.

  • Caplan MJ. . 1997 Am. J. Physiol. 272: F425–429.

  • Cascio S and Zaret KS. . 1991 Development 113: 217–225.

  • Chomczynski P and Sacchi N. . 1987 Anal. Biochem. 162: 156–159.

  • Coleman TR, Fishkind DJ, Mooseker MS and Morrow JS. . 1989 Cell Motil. Cytoskeleton 12: 225–247.

  • Cook J, Hou E, Hou Y, Cairo A and Doyle D. . 1983 J. Cell Biol. 97: 1823–1833.

  • Douarin NM. . 1975 Med. Biol. 53: 427–455.

  • Engvall E. . 1980 Methods Enzymol. 70: 419–439.

  • Gallagher PG and Forget BG. . 1993 Semin. Hematol. 30: 4–20.

  • Goodman SR, Krebs KE, Whitfield CF, Riederer BM and Zagon IS. . 1988 CRC Crit. Rev. Biochem. 23: 171–234.

  • Goodman SR and Zagon IS. . 1984 Brain. Res. Bull. 13: 813–832.

  • Goodman SR, Zagon IS and Kulikowski RR. . 1981 Proc. Natl. Acad. Sci. USA 78: 7570–7574.

  • Goodman SR, Zagon IS, Whitfield CF, Casoria LA, Shohet SB, Bernstein SE, McLaughlin PJ and Laskiewicz TL. . 1984 Am. J. Physiol. 247: C61–73.

  • Goodman SR, Zimmer WE, Clark MB, Zagon IS, Barker JE and Bloom ML. . 1995 Brain. Res. Bull. 36: 593–606.

  • Gubler U and Hoffman BJ. . 1983 Gene 25: 263–269.

  • Hammerton RW, Krzeminski KA, Mays RW, Ryan TA, Wollner DA and Nelson WJ. . 1991 Science 254: 847–850.

  • Harris HW, Jr and Lux SE. . 1980 J. Biol. Chem. 255: 11512–11520.

  • Harrison SM, Dunwoodie SL, Arkell RM, Lehrach H and Beddington RS. . 1995 Development 121: 2479–2489.

  • Houssaint E. . 1980 Cell Differ. 9: 269–279.

  • Hu RJ, Watanabe M and Bennett V. . 1992 J. Biol. Chem. 267: 18715–18722.

  • Kennedy SP, Weed SA, Forget BG and Morrow JS. . 1994 J. Biol. Chem. 269: 11400–11408.

  • Kozak M. . 1984 Nucleic Acids Res. 12: 857–872.

  • Kwon Y and Morris ME. . 1997 Pharm. Res. 14: 780–785.

  • Laemmli UK. . 1970 Nature 227: 680–685.

  • Lombardo CR, Weed SA, Kennedy SP, Forget BG and Morrow JS. . 1994 J. Biol. Chem. 269: 29212–29219.

  • Ma Y, Zimmer WE, Riederer BM, Bloom ML, Barker JE, Goodman SR and Goodman SM. . 1993 Brain Res. Mol. Brain Res. 18: 87–99.

  • Maurice M, Rogier E, Cassio D and Feldmann G. . 1988 J. Cell. Sci. 90: 79–92.

  • Mishra L, Cai T, Levine A, Weng D, Mezey E, Mishra B and Gearhart J. . 1998 Int. J. Dev. Biol. 41: 747–750.

  • Mishra L, Tully RE, Monga SP, Yu P, Cai T, Makalowski W, Mezey E, Pavan WJ and Mishra B. . 1997 Oncogene 15: 2361–2368.

  • Muller M and Jansen PL. . 1997 Am. J. Physiol. 272: G1285–1303.

  • Nelson WJ. . 1991 Biochem. Soc. Trans. 19: 1055–1059.

  • Porter GA, Dmytrenko GM, Winkelmann JC and Bloch RJ. . 1992 J. Cell. Biol. 117: 997–1005.

  • Riederer BM, Zagon IS and Goodman SR. . 1986 J. Cell. Biol. 102: 2088–2097.

  • Rowe LB, Nadeau JH, Turner R, Frankel WN, Letts VA, Eppig JT, Ko MS, Thurston SJ and Birkenmeier EH. . 1994 Mamm. Genome 5: 253–274.

  • Sambrook J, Fritsch EF and Maniatis T. . 1989 Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Press: New York.

  • Sanger F, Nicklen S and Coulson AR. . 1977 Proc. Natl. Acad. Sci. USA 74: 5463–5467.

  • Schweinfest CW, Henderson KW, Gu JR, Kottaridis SD, Besbeas S, Panotopoulou E and Papas TS. . 1990 Genet. Anal. Tech. Appl. 7: 64–70.

  • Thomas GH and Kiehart DP. . 1994 Development 120: 2039–2050.

  • Tse WT, Lecomte MC, Costa FF, Garbarz M, Feo C, Boivin P, Dhermy D and Forget BG. . 1990 J. Clin. Invest 86: 909–916.

  • Viel A and Branton D. . 1996 Curr. Opin. Cell. Biol. 8: 49–55.

  • Winkelmann JC and Forget BG. . 1993 Blood 81: 3173–3185.

  • Zimmer WE, Ma Y, Zagon IS and Goodman SR. . 1992 Brain. Res. 594: 75–83.

Download references

Acknowledgements

The authors thank Dr RJ Bloch for critical and invaluble discussions. The research was supported by National Institutes of Health grant (R29-DK50458-01). This manuscript is dedicated to Dr Geraint James and Professor Dame Sheila Sherlock.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mishra, L., Cai, T., Yu, P. et al. Elf3 encodes a novel 200-kD β-spectrin: role in liver development. Oncogene 18, 353–364 (1999). https://doi.org/10.1038/sj.onc.1202313

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202313

Keywords

Search

Quick links